- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies
U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies
UPDATED Apr 07, 2024
Companies with a Value score of at least 3, ordered by Value score
425 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
AVTB.F | CA$0.075 | 7.6% | -43.5% | CA$29.4m | n/a | PS1.1x | n/a | n/a | ||
ACET | US$2.25 | -6.3% | -60.1% | US$184.8m | US$9.60 | PB1.1x | E7.1% | n/a | ||
MDDV.F | AU$0.55 | 0% | -25.5% | AU$52.2m | AU$2.75 | PS1.6x | E66.5% | 0% | ||
PTPI | US$0.93 | -33.9% | -3.9% | US$2.0m | US$4.00 | PB0.2x | E38.3% | n/a | ||
CLRP.F | AU$1.78 | -1.1% | 250.4% | AU$808.6m | AU$2.26 | PS85.2x | E46.9% | n/a | ||
ORXO.F | kr1.51 | 0% | n/a | kr557.4m | kr2.09 | PB9.5x | E75.1% | n/a | ||
LFCR | US$6.14 | 6.0% | 64.2% | US$187.6m | US$6.00 | PS1.8x | E138.1% | n/a | ||
RCKT | US$25.01 | -6.4% | 49.1% | US$2.3b | US$50.31 | PB4.6x | E54.1% | n/a | ||
AYUR.F | CA$0.032 | 19.6% | -23.8% | CA$8.8m | n/a | PB4.6x | n/a | n/a | ||
CALT | kr21.63 | 3.0% | -8.8% | kr6.0b | kr40.24 | PS5x | E47.6% | n/a | ||
BNTC | US$5.57 | 9.2% | 49.3% | US$14.4m | US$10.06 | PS236.7x | S-171.6% | n/a | ||
IONS | US$43.22 | -1.6% | 17.1% | US$6.3b | US$58.14 | PS8x | E27.9% | n/a | ||
EOLS | US$13.26 | -3.6% | 60.3% | US$815.5m | US$22.29 | PS4x | E65.1% | n/a | ||
FENC | US$10.69 | -1.4% | 18.8% | US$289.7m | US$18.33 | PS13.6x | E50.8% | n/a | ||
AMGN | US$269.95 | -4.6% | 7.6% | US$144.7b | US$304.89 | PE21.5x | E9.1% | 3.3% | ||
PAIO.F | €0.025 | 0% | -99.6% | €249.7k | €7.06 | PE-0.01x | E69.1% | n/a | ||
LJUI.F | HK$0.70 | 0% | n/a | HK$12.9b | HK$1.06 | PE11.5x | E20.9% | 3.2% | ||
GBT | US$68.49 | 0.6% | 169.5% | US$4.6b | US$68.50 | PS19.7x | E66.2% | n/a | ||
TRSB.F | HK$0.80 | 0% | n/a | HK$13.5b | HK$1.04 | PE7.2x | E-1.1% | 3.4% | ||
KDEV.F | kr0.26 | 0% | n/a | kr520.2m | n/a | PS239.2x | S-2.6% | n/a | ||
IPSE.F | €117.60 | 0% | n/a | €8.9b | €136.90 | PE14.4x | E6.1% | 1.1% | ||
CRL | US$253.10 | -5.8% | 26.7% | US$13.0b | US$270.67 | PE27.4x | E11.4% | n/a | ||
TEVJ.F | US$14.25 | 1.8% | n/a | US$16.0b | US$15.15 | PS1x | E47.3% | 0% | ||
CHJT.F | HK$0.75 | -6.8% | -24.2% | HK$72.9b | HK$1.14 | PE11.5x | E4.5% | 4.5% |